Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
23.02
-0.46 (-1.96%)
At close: Feb 6, 2026, 4:00 PM EST
19.80
-3.22 (-13.99%)
After-hours: Feb 6, 2026, 6:40 PM EST
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 11 analysts that cover Hims & Hers Health stock have a consensus rating of "Hold" and an average price target of $41.55, which forecasts a 80.50% increase in the stock price over the next year. The lowest target is $30 and the highest is $68.
Price Target: $41.55 (+80.50%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 7 | 8 | 8 | 7 | 8 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 11 | 12 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $85 → $60 | Strong Buy | Maintains | $85 → $60 | +160.64% | Feb 2, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Initiates $33 | Hold | Initiates | $33 | +43.35% | Jan 12, 2026 |
| Barclays | Barclays | Buy Initiates $48 | Buy | Initiates | $48 | +108.51% | Dec 9, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $28 → $32 | Sell | Maintains | $28 → $32 | +39.01% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $85 | Strong Buy | Reiterates | $85 | +269.24% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
2.40B
from 1.48B
Increased by 62.27%
Revenue Next Year
2.83B
from 2.40B
Increased by 17.90%
EPS This Year
0.48
from 0.53
Decreased by -10.73%
EPS Next Year
0.58
from 0.48
Increased by 23.08%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.5B | 3.1B | ||||
| Avg | 2.4B | 2.8B | ||||
| Low | 2.3B | 2.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 68.6% | 30.8% | ||||
| Avg | 62.3% | 17.9% | ||||
| Low | 55.2% | 3.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | 0.61 | 1.44 | ||
| Avg | 0.48 | 0.58 | ||
| Low | 0.26 | -0.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | 14.4% | 202.7% | ||
| Avg | -10.7% | 23.1% | ||
| Low | -50.3% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.